Combined Immuno-Chemotherapy (R-CHOP) Results in Significantly Superior Response Rates and Time to Treatment Failure in First Line Treatment of Patients with Lymphomplasmocytoid/ic Immunocytoma (LP-IC) - Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG).
暂无分享,去创建一个
W. Hiddemann | C. Buske | M. Pfreundschuh | W. Schmiegel | W. Ludwig | M. Dreyling | E. Kreuser | B. Metzner | H. Wandt | M. Unterhalt | R. Fuchs | B. Woermann | G. Hess | J. Schimke | S. Schmitz | L. Truemper | H. Eimermacher | H. Weh | H. Boeck